A client with chronic asthma receives a prescription for montelukast, a leukotriene modifier. Which statement by the client indicates to the nurse that medication teaching was effective?
I should take this medication only when I am having an asthma attack.
I will not need to use my inhalers twice a day when I start this medicine.
I will take the tablet every evening to control my asthma.
This medication will stop an asthma attack immediately.
The Correct Answer is C
Choice A Reason:
I should take this medication only when I am having an asthma attack: This statement is incorrect because montelukast is not a rescue medication. It is a maintenance medication designed to be taken regularly to prevent asthma symptoms and attacks. Using it only during an asthma attack would not provide the intended preventive benefits.
Choice B Reason:
I will not need to use my inhalers twice a day when I start this medicine: This statement is also incorrect. Montelukast is often used as an adjunct therapy and does not replace the need for inhalers, especially for those with moderate to severe asthma. Inhalers, particularly corticosteroids, remain a critical part of asthma management.
Choice C Reason:
I will take the tablet every evening to control my asthma: This statement is correct. Montelukast is typically prescribed to be taken once daily in the evening. This helps to control asthma symptoms and prevent attacks by reducing inflammation and constriction in the airways.
Choice D Reason:
This medication will stop an asthma attack immediately: This statement is incorrect. Montelukast is not a fast-acting medication and will not provide immediate relief during an asthma attack. Fast-acting bronchodilators, such as albuterol, are used for immediate relief.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
Choice A reason: While it is true that breastfeeding is not recommended while taking isotretinoin due to the potential for adverse effects on the infant, this is not the most critical information for a client planning to become pregnant. The primary concern is the teratogenic effects of isotretinoin, which can cause severe birth defects.
Choice B reason: Advising the client not to take multiple vitamins that contain vitamin A while on isotretinoin is important because excessive vitamin A can increase the risk of toxicity. However, this is not the most crucial information for someone planning to become pregnant. The teratogenic risks of isotretinoin are a higher priority.
Choice C reason: Obtaining baseline liver function results is necessary during isotretinoin therapy due to the potential for hepatotoxicity. Regular monitoring helps ensure the liver is functioning properly. However, this information is secondary to the need to avoid pregnancy while on isotretinoin due to its severe teratogenic effects.
Choice D reason: Discontinuing isotretinoin one month before attempting to conceive is the most important information. Isotretinoin is highly teratogenic and can cause serious birth defects. It is crucial to stop the medication well before conception to ensure it is completely cleared from the body, reducing the risk of harm to the fetus.
Correct Answer is C
Explanation
Choice A reason: Potassium levels are not directly affected by calcium acetate. Calcium acetate is primarily used to manage hyperphosphatemia in patients with CKD by binding to dietary phosphate and preventing its absorption1. Therefore, a decrease in potassium levels would not indicate the effectiveness of calcium acetate.
Choice B reason: Calcium acetate can actually increase calcium levels in the blood, especially if taken in high doses or if the patient has other sources of calcium intake. Monitoring calcium levels is important to avoid hypercalcemia, but a decrease in calcium levels is not the desired effect of this medication.
Choice C reason: Calcium acetate is used to reduce serum phosphate levels in patients with CKD. It works by binding to dietary phosphate in the gastrointestinal tract, forming insoluble calcium phosphate, which is then excreted in the stool. A decrease in serum phosphate levels indicates that the medication is effectively reducing phosphate absorption and managing hyperphosphatemia.
Choice D reason: The pH level of the blood is not directly influenced by calcium acetate. While maintaining acid-base balance is important in CKD management, the primary goal of calcium acetate therapy is to control phosphate level. Therefore, changes in blood pH are not a measure of the medication’s effectiveness.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.